MOLECULAR PROFILING OF P53 MUTANT ENDOMETRIAL CANCER REVEALS DISTINCT SUBGROUPS WITH OPPORTUNITIES FOR PERSONALIZED THERAPEUTIC APPROACHES

被引：0

作者：

Blanc-Durand, Felix ^{[1
]}

Kramer, Claire J. H. ^{[2
,3
]}

Rouleau, Etienne ^{[4
]}

Vasseur, Antoine ^{[4
]}

Bosse, Tjalling ^{[5
]}

De Boer, Stephanie ^{[6
]}

Edmondson, Richard ^{[7
]}

Powell, Melanie ^{[8
]}

Crosbie, Emma ^{[7
]}

Singh, Naveena ^{[9
]}

Mcalpine, Jessica ^{[9
]}

Mackay, Helen ^{[10
]}

Pollock, Pamela ^{[11
]}

Mileshkin, Linda ^{[12
]}

Scott, Clare ^{[13
]}

Lim, Yi Wan ^{[14
]}

Lim, Siew Eng ^{[15
]}

Ngoi, Natalie Yan Li ^{[14
]}

Tan, David ^{[15
]}

Leary, Alexandra ^{[1
]}

机构：

[1] Inst Gustave Roussy, Med Oncol, Villejuif, France

[2] Leiden Univ, Med Ctr, Leiden, Netherlands

[3] DGOG, Dept Pathol, Leiden, Netherlands

[4] Inst Gustave Roussy, Canc Biol, Villejuif, France

[5] Leids Univ Med Ctr LUMC, Dept Pathol, Leiden, Netherlands

[6] Leiden Univ Med Ctr, Radiat Oncol, Leiden, Netherlands

[7] Manchester Acad Hlth Sci Ctr, Med Oncol, Manchester, Lancs, England

[8] St Bartholomews Hosp, Med Oncol, London, England

[9] Vancouver Gen Hosp, Pathol, Vancouver, BC, Canada

[10] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Med Oncol, Toronto, ON, Canada

[11] Queenslans Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia

[12] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia

[13] Walter & Eliza Hall Med Res Inst, Clin Translat Ctr, Melbourne, Vic, Australia

[14] Natl Univ Canc Inst, Med Oncol, Singapore, Singapore

[15] Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期

关键词：

D O I：

10.1136/ijgc-2023-IGCS.66

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

PR024

引用

页码：A44 / A44

页数：1

共 50 条

[21] The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches
Joerger, Andreas C.
Fersht, Alan R.
ANNUAL REVIEW OF BIOCHEMISTRY, VOL 85, 2016, 85 : 375 - 404
[22] Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
Pei Woon Ang
Marie Loh
Natalia Liem
Pei Li Lim
Fabienne Grieu
Aparna Vaithilingam
Cameron Platell
Wei Peng Yong
Barry Iacopetta
Richie Soong
BMC Cancer, 10
[23] Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
Ang, Pei Woon
Loh, Marie
Liem, Natalia
Lim, Pei Li
Grieu, Fabienne
Vaithilingam, Aparna
Platell, Cameron
Yong, Wei Peng
Iacopetta, Barry
Soong, Richie
BMC CANCER, 2010, 10
[24] Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Shinjinee Sengupta
Shaikh Maryam Ghufran
Aqsa Khan
Subhrajit Biswas
Susanta Roychoudhury
Cancer Cell International, 22
[25] Transition of amyloid/mutant p53 from tumor suppressor to an oncogene and therapeutic approaches to ameliorate metastasis and cancer stemness
Sengupta, Shinjinee
Ghufran, Shaikh Maryam
Khan, Aqsa
Biswas, Subhrajit
Roychoudhury, Susanta
CANCER CELL INTERNATIONAL, 2022, 22 (01)
[26] Markers of the p53 pathway further refine molecular profiling in high-risk endometrial cancer: A TransPORTEC initiative
Edmondson, R. J.
Crosbie, E. J.
Nickkho-Amiry, M.
Kaufmann, A.
Stelloo, E.
Nijman, H. W.
Leary, A.
Auguste, A.
Mileshkin, L.
Pollock, P.
MacKay, H. J.
Powell, M. E.
Bosse, T.
Creutzberg, C. L.
Kitchener, H. C.
GYNECOLOGIC ONCOLOGY, 2017, 146 (02) : 327 - 333
[27] COMPREHENSIVE DNA METHYLATION PROFILING REVEALS THREE SUBGROUPS OF COLORECTAL CANCER WITH DISTINCT CLINICOPATHOLOGICAL AND MOLECULAR FEATURES
Lacopetta, B.
Ang, S.
Loh, M.
Grieu, F.
Platell, C.
Soong, R.
ANNALS OF ONCOLOGY, 2010, 21 : 11 - 11
[28] Molecular interplay between mutant p53 proteins and autophagy in cancer cells
Cordani, Marco
Butera, Giovanna
Pacchiana, Raffaella
Donadelli, Massimo
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2017, 1867 (01): : 19 - 28
[29] Mutant p53 as a Therapeutic Target for the Treatment of Triple-Negative Breast Cancer
Synnott, N.
Crown, J.
Duffy, M. J.
EUROPEAN JOURNAL OF CANCER, 2018, 103 : E41 - E41
[30] Endoplasmic reticulum (ER), a potential therapeutic target for mutant p53 colorectal cancer
Tyagi, Ashish
Chandrasekaran, Balaji
Kolluru, Venkatesh
Baby, Becca V.
Houda, Alatassi
Ramisetti, Srinivasa
Sharma, Arun
Ankem, Murali
Damodaran, Chendil
CANCER RESEARCH, 2019, 79 (13)

← 1 2 3 4 5 →